Reshuffles in Pharma & CROs To Affect Research Collab
Predictions for Q4 2025-Q1 2026 indicate significant workforce reshuffles in pharmaceuticals and CROs (Contract Research Organisations), which could indirectly affect research collaborations with ICMR or scientific units. This trend points to cost-cutting and restructuring amid economic pressu

Comments (0)
No comments yet. Be the first.